VectivBio AG is a clinical-stage biotechnology company focused on transformational therapeutics for rare diseases, spun out from Therachon in 2019. The company draws on the expertise of its founders to build a portfolio of rare disease medicines while advancing apraglutide for Short Bowel Syndrome.

Products, services, technology

Apraglutide for Short Bowel Syndrome.

Location

Aeschenvorstadt 41, 4051 Basel, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation

    2019

  • Number of employees in Switzerland

    10-19

Key business